Cellular response upon proliferation in the presence of an active mitotic checkpoint.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
06 2019
Historique:
received: 13 03 2019
revised: 26 04 2019
accepted: 29 04 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 10 5 2019
Statut: epublish

Résumé

Eukaryotic cells treated with microtubule-targeting agents activate the spindle assembly checkpoint to arrest in mitosis and prevent chromosome mis-segregation. A fraction of mitotically arrested cells overcomes the block and proliferates even under persistent checkpoint-activating conditions. Here, we asked what allows proliferation in such unfavourable conditions. We report that yeast cells are delayed in mitosis at each division, implying that their spindle assembly checkpoint remains responsive. The arrest causes their cell cycle to be elongated and results in a size increase. Growth saturates at mitosis and correlates with the repression of various factors involved in translation. Contrary to unperturbed cells, growth of cells with an active checkpoint requires Cdh1. This peculiar cell cycle correlates with global changes in protein expression whose signatures partly overlap with the environmental stress response. Hence, cells dividing with an active checkpoint develop recognisable specific traits that allow them to successfully complete cell division notwithstanding a constant mitotic checkpoint arrest. These properties distinguish them from unperturbed cells. Our observation may have implications for the identification of new therapeutic windows and targets in tumors.

Identifiants

pubmed: 31068378
pii: 2/3/e201900380
doi: 10.26508/lsa.201900380
pmc: PMC6507650
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019 Corno et al.

Références

J Cell Biol. 2013 Apr 15;201(2):177-89
pubmed: 23589490
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12644-9
pubmed: 22802626
J Cell Biol. 2013 Sep 2;202(5):765-78
pubmed: 23999167
Nature. 2014 Oct 30;514(7524):646-9
pubmed: 25156254
Elife. 2018 Jul 04;7:
pubmed: 29972352
Mol Cell. 2000 Mar;5(3):501-11
pubmed: 10882135
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Science. 1998 Feb 13;279(5353):1041-4
pubmed: 9461437
Nat Protoc. 2018 Mar;13(3):530-550
pubmed: 29446774
Curr Biol. 2018 Jan 8;28(1):28-37.e7
pubmed: 29249657
Mol Cell Biol. 2005 Mar;25(5):1860-8
pubmed: 15713640
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Curr Biol. 2006 Jun 20;16(12):1194-200
pubmed: 16782009
Curr Biol. 2012 Oct 23;22(20):1900-8
pubmed: 23000150
J Cell Biol. 2000 Jun 26;149(7):1377-90
pubmed: 10871279
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Mol Cell. 1998 Dec;2(6):709-18
pubmed: 9885559
Dev Cell. 2003 May;4(5):741-52
pubmed: 12737808
J Cell Biol. 1988 Jun;106(6):1997-2010
pubmed: 3290223
Cancer Cell. 2008 Aug 12;14(2):111-22
pubmed: 18656424
Nat Cell Biol. 2013 Nov;15(11):1370-7
pubmed: 24096243
Cell. 1997 Aug 22;90(4):683-93
pubmed: 9288748
Nat Commun. 2018 Aug 16;9(1):3275
pubmed: 30115907
EMBO J. 2001 Dec 3;20(23):6648-59
pubmed: 11726501
Cell. 2019 Feb 21;176(5):1083-1097.e18
pubmed: 30739799
Cell. 2013 Dec 5;155(6):1244-57
pubmed: 24315096
Mol Syst Biol. 2009;5:328
pubmed: 19920813
Genetics. 1973 Jun;74(2):267-86
pubmed: 17248617
Mol Biol Cell. 2000 Dec;11(12):4241-57
pubmed: 11102521
Nature. 2015 Oct 8;526(7572):268-72
pubmed: 26390151
Cell. 2015 Oct 22;163(3):549-59
pubmed: 26496602
Curr Biol. 2015 Oct 19;25(20):R1002-18
pubmed: 26485365
Science. 2007 Aug 17;317(5840):916-24
pubmed: 17702937
Mol Biol Cell. 2011 Jul 15;22(14):2448-57
pubmed: 21593209
Science. 1997 Oct 17;278(5337):460-3
pubmed: 9334304
Genes Dev. 2009 Jun 15;23(12):1408-22
pubmed: 19528319
Nature. 2002 Aug 1;418(6897):556-62
pubmed: 12152084
Nature. 2015 Jan 29;517(7536):631-4
pubmed: 25383541
Curr Biol. 2017 Sep 25;27(18):2774-2783.e3
pubmed: 28889980
J Cell Biol. 2010 Nov 29;191(5):981-97
pubmed: 21098112
Nat Cell Biol. 2003 Dec;5(12):1090-4
pubmed: 14634663

Auteurs

Andrea Corno (A)

Istituto Firc di Oncologia Molecolare, Milan, Italy.

Elena Chiroli (E)

Istituto Firc di Oncologia Molecolare, Milan, Italy.

Fridolin Gross (F)

Istituto Firc di Oncologia Molecolare, Milan, Italy.

Claudio Vernieri (C)

Istituto Firc di Oncologia Molecolare, Milan, Italy.
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Vittoria Matafora (V)

Istituto Firc di Oncologia Molecolare, Milan, Italy.

Stefano Maffini (S)

Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.

Marco Cosentino Lagomarsino (M)

Istituto Firc di Oncologia Molecolare, Milan, Italy.
Physics Department, University of Milan, Milan, Italy.

Angela Bachi (A)

Istituto Firc di Oncologia Molecolare, Milan, Italy.

Andrea Ciliberto (A)

Istituto Firc di Oncologia Molecolare, Milan, Italy andrea.ciliberto@ifom.eu.
Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, Pavia, Italy.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae

Classifications MeSH